Stubbs D, Ruzicka J, Taylor E
Pathogens. 2024; 13(10).
PMID: 39452701
PMC: 11510084.
DOI: 10.3390/pathogens13100829.
Mueller H, Erameh C, Gelderblom M, Edeawe O, Akpasubi O, Ekoyata E
PLoS Negl Trop Dis. 2024; 18(10):e0012522.
PMID: 39356691
PMC: 11446436.
DOI: 10.1371/journal.pntd.0012522.
Morales-Tenorio M, Lasala F, Garcia-Rubia A, Aledavood E, Heung M, Olal C
J Med Chem. 2024; 67(18):16381-16402.
PMID: 39248591
PMC: 11440591.
DOI: 10.1021/acs.jmedchem.4c01267.
Hayat M, Gao T, Cao Y, Rafiq M, Zhuo L, Li Y
Biomolecules. 2024; 14(6).
PMID: 38927063
PMC: 11201620.
DOI: 10.3390/biom14060660.
Nurmukanova V, Matsvay A, Gordukova M, Shipulin G
Viruses. 2024; 16(5).
PMID: 38793668
PMC: 11126052.
DOI: 10.3390/v16050787.
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors.
Broni E, Ashley C, Adams J, Manu H, Aikins E, Okom M
Int J Mol Sci. 2023; 24(7).
PMID: 37047270
PMC: 10094735.
DOI: 10.3390/ijms24076298.
'-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile.
Garcia-Rubia A, Lasala F, Ginex T, Morales-Tenorio M, Olal C, Heung M
J Med Chem. 2023; 66(8):5465-5483.
PMID: 37021830
PMC: 10150359.
DOI: 10.1021/acs.jmedchem.2c01785.
Natural history of nonhuman primates after conjunctival exposure to Ebola virus.
Cross R, Prasad A, Woolsey C, Agans K, Borisevich V, Dobias N
Sci Rep. 2023; 13(1):4175.
PMID: 36914721
PMC: 10011569.
DOI: 10.1038/s41598-023-31027-7.
Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal cohort study.
Kelly J, Van Ryn C, Badio M, Fayiah T, Johnson K, Gayedyu-Dennis D
Lancet Infect Dis. 2022; 22(8):1163-1171.
PMID: 35588755
PMC: 9329265.
DOI: 10.1016/S1473-3099(22)00127-X.
Post-viral mental health sequelae in infected persons associated with COVID-19 and previous epidemics and pandemics: Systematic review and meta-analysis of prevalence estimates.
Zurcher S, Banzer C, Adamus C, Lehmann A, Richter D, Kerksieck P
J Infect Public Health. 2022; 15(5):599-608.
PMID: 35490117
PMC: 9020842.
DOI: 10.1016/j.jiph.2022.04.005.
Alzheimer's-like signaling in brains of COVID-19 patients.
Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks A
Alzheimers Dement. 2022; 18(5):955-965.
PMID: 35112786
PMC: 9011576.
DOI: 10.1002/alz.12558.
Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds.
Darko L, Broni E, Amuzu D, Wilson M, Parry C, Kwofie S
Biomedicines. 2021; 9(12).
PMID: 34944612
PMC: 8698941.
DOI: 10.3390/biomedicines9121796.
Modulating Neurological Complications of Emerging Infectious Diseases: Mechanistic Approaches to Candidate Phytochemicals.
Fakhri S, Pour P, Piri S, Farzaei M, Echeverria J
Front Pharmacol. 2021; 12:742146.
PMID: 34764869
PMC: 8576094.
DOI: 10.3389/fphar.2021.742146.
Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model.
Lee H, McWilliams I, Lewkowicz A, Engel K, Ireland D, Kelley-Baker L
Emerg Microbes Infect. 2021; 10(1):2076-2089.
PMID: 34674613
PMC: 8583756.
DOI: 10.1080/22221751.2021.1997075.
Longitudinal in vivo imaging of acute neuropathology in a monkey model of Ebola virus infection.
Schreiber-Stainthorp W, Solomon J, Lee J, Castro M, Shah S, Martinez-Orengo N
Nat Commun. 2021; 12(1):2855.
PMID: 34001896
PMC: 8129091.
DOI: 10.1038/s41467-021-23088-x.
Neurologic Manifestations of the World Health Organization's List of Pandemic and Epidemic Diseases.
McEntire C, Song K, McInnis R, Rhee J, Young M, Williams E
Front Neurol. 2021; 12:634827.
PMID: 33692745
PMC: 7937722.
DOI: 10.3389/fneur.2021.634827.
Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives.
Roychoudhury S, Das A, Sengupta P, Dutta S, Roychoudhury S, Paul Choudhury A
Int J Environ Res Public Health. 2020; 17(24).
PMID: 33333995
PMC: 7765415.
DOI: 10.3390/ijerph17249411.
Neuroethical and Societal Challenges of 21st Century Epidemics.
Minielly N, Feehan C, Wong A, Illes J
Trends Neurosci. 2020; 43(12):960-964.
PMID: 33153756
PMC: 7580694.
DOI: 10.1016/j.tins.2020.10.006.
The neurological sequelae of pandemics and epidemics.
Valerio F, Whitehouse D, Menon D, Newcombe V
J Neurol. 2020; 268(8):2629-2655.
PMID: 33106890
PMC: 7587542.
DOI: 10.1007/s00415-020-10261-3.
Immunological Perspective for Ebola Virus Infection and Various Treatment Measures Taken to Fight the Disease.
Jain S, Khaiboullina S, Baranwal M
Pathogens. 2020; 9(10).
PMID: 33080902
PMC: 7603231.
DOI: 10.3390/pathogens9100850.